【摘要】 目前临床上对于肝癌患者的肝功能评估和治疗相关的预后预测仍以Child-Pugh评分为主，但在实施“精准医学”的年代越显其存在着明显不足之处。本文就近年来利用ALBI分级（白蛋白-胆红素分级）在接受不同方式治疗的肝癌的患者的疗效评估、预后预测方面的应用、ALBI分级的优、缺点加以总结，并将近年来将其应用于预测模型的研究现状进行综述，以为临床工作提供更大的帮助。更多还原

【Abstract】 The major tool for liver function assessment and prognosis stratification for patients with hepatocellular carcinoma is Child-Pugh score. Nevertheless,the accuracy of the Child-Pugh score on this topic is limited by its disadvantages. With the aim to provide better clinical evidence and benefits,the review article summarized the ability of the albumin-bilirubin(ALBI)grade in evaluating the efficacy and predicting the prognosis of various treatments for patients with hepatocellular carcinoma(HCC)as well as the advantages and disadvantages of ALBI classification. In addition,ALBI grade-based prognostic models for HCC were also reviewed.更多还原